Kenvue Inc. (KVUE) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and...
Kenvue Inc. (KVUE) currently trades at a P/E ratio of 22.89 (historical range: 18.95–44.55, median: 28.13), placing it at the 31th percentile — below its historical average, P/S ratio of 2.43 (range: 1.81–3.07, 46th percentile — near its historical average), EV/EBITDA of 49.07 (range: 13.50–86.77, 81th percentile).
Over the historical period (2024-08-30 to 2026-08-28), Kenvue Inc.'s P/E ratio has contracted by 41% over the observed period (from an average of 38.3 to 22.5).
Kenvue Inc. appears fairly valued relative to its historical range, with valuation metrics near their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 22.89 | 18.95 | 28.13 | 44.55 | 31th | below its historical average |
| P/S Ratio | 2.43 | 1.81 | 2.58 | 3.07 | 46th | near its historical average |
| EV/EBITDA | 49.07 | 13.50 | 32.80 | 86.77 | 81th | expensive relative to its history |
| FCF Yield | 0.01 | 0.01 | 0.02 | 0.05 | 15th | expensive relative to its history |